Mark Edward Huser, MD | |
3264 N Evergreen Dr Ne, Grand Rapids, MI 49525-9746 | |
(616) 363-7272 | |
(616) 361-5828 |
Full Name | Mark Edward Huser |
---|---|
Gender | Male |
Speciality | Diagnostic Radiology |
Experience | 11 Years |
Location | 3264 N Evergreen Dr Ne, Grand Rapids, Michigan |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1881937316 | NPI | - | NPPES |
831215 | Medicaid | AZ | |
82655758 | Medicaid | NM |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
2085R0202X | Radiology - Diagnostic Radiology | MD2019-0036 (New Mexico) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Spectrum Health | Grand rapids, MI | Hospital |
North Shore University Hospital | Manhasset, NY | Hospital |
Long Island Jewish Medical Center | New hyde park, NY | Hospital |
Lakeland Hospital, St Joseph | St joseph, MI | Hospital |
Lenox Hill Hospital | New york, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Advanced Radiology Services Pc | 4284546516 | 235 |
Spartan Radiology Inc | 5698003697 | 179 |
North Shore - Lij Medical Pc | 3375701568 | 5099 |
Southside Faculty Medical Affiliates University Faculty Prac | 5698175933 | 158 |
News Archive
The Nanodermatology Society (NDS), a physician-led organization dedicated to the scientific and medical aspects of nanotechnology and dermatology, released its first position statement on the safety of nanotechnology in sunscreens.
Cancer Research UK scientists have shown that it may soon be possible to offer women a genetic test to assess their risk of breast cancer which could aid early diagnosis for those at high risk of the disease. Their findings are revealed in the New England Journal of Medicine today (Wednesday).
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
Up to one-third of physicians reported sending patients for a thyroid ultrasound for reasons not supported by clinical care guidelines, a new study led by University of Michigan Rogel Cancer Center researchers finds.
The practice of extracting baby canine teeth to make way for adult canines that are erupting in the wrong place has no evidential basis, according to a new study by Cochrane Researchers.
› Verified 5 days ago
Entity Name | Advanced Radiology Services Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1740283324 PECOS PAC ID: 4284546516 Enrollment ID: O20201202003080 |
News Archive
The Nanodermatology Society (NDS), a physician-led organization dedicated to the scientific and medical aspects of nanotechnology and dermatology, released its first position statement on the safety of nanotechnology in sunscreens.
Cancer Research UK scientists have shown that it may soon be possible to offer women a genetic test to assess their risk of breast cancer which could aid early diagnosis for those at high risk of the disease. Their findings are revealed in the New England Journal of Medicine today (Wednesday).
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
Up to one-third of physicians reported sending patients for a thyroid ultrasound for reasons not supported by clinical care guidelines, a new study led by University of Michigan Rogel Cancer Center researchers finds.
The practice of extracting baby canine teeth to make way for adult canines that are erupting in the wrong place has no evidential basis, according to a new study by Cochrane Researchers.
› Verified 5 days ago
Entity Name | Spartan Radiology Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1932768058 PECOS PAC ID: 5698003697 Enrollment ID: O20201208001253 |
News Archive
The Nanodermatology Society (NDS), a physician-led organization dedicated to the scientific and medical aspects of nanotechnology and dermatology, released its first position statement on the safety of nanotechnology in sunscreens.
Cancer Research UK scientists have shown that it may soon be possible to offer women a genetic test to assess their risk of breast cancer which could aid early diagnosis for those at high risk of the disease. Their findings are revealed in the New England Journal of Medicine today (Wednesday).
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
Up to one-third of physicians reported sending patients for a thyroid ultrasound for reasons not supported by clinical care guidelines, a new study led by University of Michigan Rogel Cancer Center researchers finds.
The practice of extracting baby canine teeth to make way for adult canines that are erupting in the wrong place has no evidential basis, according to a new study by Cochrane Researchers.
› Verified 5 days ago
Entity Name | Southside Faculty Medical Affiliates University Faculty Prac |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1033791058 PECOS PAC ID: 5698175933 Enrollment ID: O20240115001443 |
News Archive
The Nanodermatology Society (NDS), a physician-led organization dedicated to the scientific and medical aspects of nanotechnology and dermatology, released its first position statement on the safety of nanotechnology in sunscreens.
Cancer Research UK scientists have shown that it may soon be possible to offer women a genetic test to assess their risk of breast cancer which could aid early diagnosis for those at high risk of the disease. Their findings are revealed in the New England Journal of Medicine today (Wednesday).
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
Up to one-third of physicians reported sending patients for a thyroid ultrasound for reasons not supported by clinical care guidelines, a new study led by University of Michigan Rogel Cancer Center researchers finds.
The practice of extracting baby canine teeth to make way for adult canines that are erupting in the wrong place has no evidential basis, according to a new study by Cochrane Researchers.
› Verified 5 days ago
Entity Name | North Shore - Lij Medical Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1053688572 PECOS PAC ID: 3375701568 Enrollment ID: O20240306001315 |
News Archive
The Nanodermatology Society (NDS), a physician-led organization dedicated to the scientific and medical aspects of nanotechnology and dermatology, released its first position statement on the safety of nanotechnology in sunscreens.
Cancer Research UK scientists have shown that it may soon be possible to offer women a genetic test to assess their risk of breast cancer which could aid early diagnosis for those at high risk of the disease. Their findings are revealed in the New England Journal of Medicine today (Wednesday).
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
Up to one-third of physicians reported sending patients for a thyroid ultrasound for reasons not supported by clinical care guidelines, a new study led by University of Michigan Rogel Cancer Center researchers finds.
The practice of extracting baby canine teeth to make way for adult canines that are erupting in the wrong place has no evidential basis, according to a new study by Cochrane Researchers.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Mark Edward Huser, MD 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525-9746 Ph: (616) 363-7272 | Mark Edward Huser, MD 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525-9746 Ph: (616) 363-7272 |
News Archive
The Nanodermatology Society (NDS), a physician-led organization dedicated to the scientific and medical aspects of nanotechnology and dermatology, released its first position statement on the safety of nanotechnology in sunscreens.
Cancer Research UK scientists have shown that it may soon be possible to offer women a genetic test to assess their risk of breast cancer which could aid early diagnosis for those at high risk of the disease. Their findings are revealed in the New England Journal of Medicine today (Wednesday).
Epitomics, Inc., a biotechnology company commercializing the next generation of antibodies based on its groundbreaking Rabbit Monoclonal Antibody (RabMAb®) technology, today announced that the Company has signed a contract with SAIC Frederick, Inc., operating under contract with the National Cancer Institute (NCI) of the U.S. National Institutes of Health (NIH) to develop several dozen rabbit monoclonal antibodies to support the Clinical Proteomic Technologies for Cancer (CPTC) program (www.proteomics.cancer.gov).
Up to one-third of physicians reported sending patients for a thyroid ultrasound for reasons not supported by clinical care guidelines, a new study led by University of Michigan Rogel Cancer Center researchers finds.
The practice of extracting baby canine teeth to make way for adult canines that are erupting in the wrong place has no evidential basis, according to a new study by Cochrane Researchers.
› Verified 5 days ago
Dr. Jon R Henke, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 Fax: 616-363-7290 | |
Geoffrey M. Remes, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7339 Fax: 616-361-5828 | |
Jan L Mourelatos, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 Fax: 616-361-5828 | |
Dr. Brendan Michael Banyon, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 | |
Dr. Joseph J Junewick, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7272 Fax: 616-363-7290 | |
Keith Alan Morrow, D.O. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7339 Fax: 616-361-5828 | |
Dr. Andrew Kent Moriarity, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 3264 N Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-363-7339 |